Treprostinil
Links shared publicly online about this topic
The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension
tar.sagepub.com — “The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension” View full resource at tar.sagepub.com
Most Recently Shared on February 28, 2011 at 5:01 pm By:
The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension. http://bit.ly/e7wEZD
Infectious Dis. Medical News about treprostinil
mdlinx.com — “Stability and antimicrobial effectiveness of treprostinil sodium in Sterile Diluent for Flolan” View full resource at mdlinx.com
Most Recently Shared on May 27, 2010 at 5:08 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Stability and antimicrobial effectiveness of treprostinil sodium in Sterile Diluent for Flolan: International J... http://bit.ly/dv8tgx #ID
FDA Approves Tyvaso (treprostinil) Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension
drugs.com — “Tyvaso (treprostinil) is used to treat Pulmonary Arterial Hypertension. Includes Tyvaso side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on July 31, 2009 at 3:51 am By:
FDA Approves Tyvaso (treprostinil) Inhalation Solution for Pulmonary Arterial Hypertension - http://bit.ly/w1huZ
A Medicines Management Review of Treprostinil Sodium (Remodulin) in Pulmonary Arterial Hypertension | Cardiology
touchcardiology.com — “Title: A Medicines Management Review of Treprostinil Sodium (Remodulin) in Pulmonary Arterial Hypertensionshort title: A Medicines Management Review of Treprostinil Sodium (Remodulin) in Pulmonary Arterial HypertensionShort” View full resource at touchcardiology.com
Most Recently Shared on July 1, 2010 at 12:30 pm By:
Touch Cardiology Cardiology and Health News
A Medicines Management Review of Treprostinil Sodium (Remodulin®) in Pulmonary Arterial Hypertension http://ow.ly/25ESv
United Therapeutics Corporation - FDA Approves TYVASO (Treprostinil) Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension
ir.unither.com — “United Therapeutics Corporation - FDA Approves TYVASO (Treprostinil) Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension” View full resource at ir.unither.com
Most Recently Shared on July 31, 2009 at 1:12 pm By:
Dr. Warren Rosenblum Doctor, Internist, Cardiologist, and Physician
FDA approves inhaled Treprostinil (Tyvaso) for the treatment of Pulmonary Hypertension. http://tinyurl.com/kw89ks
FREEDOM-C(2) Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Does Not Meet Primary Endpoint - Drugs.com MedNews
drugs.com — “Conference Call to be Held at 9 00 a.m. Eastern Time on August 24, 2011 United Therapeutics Corporation (NASDAQ UTHR) announced today the completion of its FREE” View full resource at drugs.com
Most Recently Shared on August 24, 2011 at 2:10 pm By:
Drugs and Devices OW OW Health
FREEDOM-C(2) Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Does Not Meet Primary Endpoint:... http://t.co/w6H23Ib #drug
Medical News: PAH Drug Outperforms Expectations - in Pulmonology, General Pulmonology from MedPage Today
medpagetoday.com — “The pulmonary arterial hypertension drug treprostinil (Remodulin) may be more effective than it's often given credit for, researchers said.” View full resource at medpagetoday.com
Most Recently Shared on December 18, 2009 at 3:07 pm By:
PAH Drug Outperforms Expectations (CME/CE, with audio) The pulmonary arterial hypertension drug treprostinil (Remodul.. http://bit.ly/6yPYFY
Pediatrics Article | Hypertension, Pulmonary
mdlinx.com — “Add-On Therapy with Subcutaneous Treprostinil for Refractory Pediatric Pulmonary Hypertension” View full resource at mdlinx.com
Most Recently Shared on November 2, 2010 at 9:36 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Add-On Therapy with Subcutaneous Treprostinil for Refractory Pediatric Pulmonary Hypertension: The Journal of... http://bit.ly/ckrm2x #peds
Cardiology Medical News about Hypertension, Pulmonary
mdlinx.com — “Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: A placebo-controlled trial” View full resource at mdlinx.com
Most Recently Shared on February 2, 2010 at 6:31 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Cardio: Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial http://url4.eu/1IRJv
Cardiology Medical News about Hypertension
mdlinx.com — “Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension: A Randomized Controlled Clinical Trial” View full resource at mdlinx.com
Most Recently Shared on April 28, 2010 at 6:00 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension: A Randomized ... http://bit.ly/bfh6ld #cardio #mdlinx
Elsevier
jhltonline.org — “Elsevier” View full resource at jhltonline.org
Most Recently Shared on November 14, 2011 at 4:46 pm By:
Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: The TReprostinil sod... http://t.co/am5XvoWc
Tyvaso approved for pulmonary arterial hypertension (PAH) - MPR
empr.com — “The FDA has approved Tyvaso (treprostinil inhalation solution, from United Therapeutics), a prostacyclin vasodilator, for the treatment of pulmonary arterial hypertension (PAH) using the Tyvaso Inhalation System.” View full resource at empr.com
Most Recently Shared on July 30, 2009 at 8:18 pm By:
MPR News: Tyvaso approved for pulmonary arterial hypertension (PAH): The FDA has approved Tyvaso (trepr.. http://bit.ly/UGQxc
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Symposier Pneumology
Symposier.com, the technological platform that will allow you (and your colleagues) to share medical information, and much more with medicine professionals.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
Advertisement
